CARsgen Therapeutics Holdings (HKSE:02171) Scaled Net Operating Assets : -0.12 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CARsgen Therapeutics Holdings Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

CARsgen Therapeutics Holdings's operating assets for the quarter that ended in Dec. 2024 was HK$207.10 Mil. CARsgen Therapeutics Holdings's operating liabilities for the quarter that ended in Dec. 2024 was HK$480.35 Mil. CARsgen Therapeutics Holdings's Total Assets for the quarter that ended in Jun. 2024 was HK$2,263.43 Mil. Therefore, CARsgen Therapeutics Holdings's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was -0.12.

CARsgen Therapeutics Holdings Scaled Net Operating Assets Historical Data

The historical data trend for CARsgen Therapeutics Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CARsgen Therapeutics Holdings Scaled Net Operating Assets Chart

CARsgen Therapeutics Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Scaled Net Operating Assets

Get a 7-Day Free Trial

-8.56

0.27

0.08

0.01

-0.11

CARsgen Therapeutics Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial						0.09	0.05	0.01	0.03	-0.12

Competitive Comparison of CARsgen Therapeutics Holdings's Scaled Net Operating Assets

For the Biotechnology subindustry, CARsgen Therapeutics Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CARsgen Therapeutics Holdings's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CARsgen Therapeutics Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where CARsgen Therapeutics Holdings's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

CARsgen Therapeutics Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

CARsgen Therapeutics Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2024 )
=	(Operating Assets (A: Dec. 2024 )	-	Operating Liabilities (A: Dec. 2024 ))	/	Total Assets (A: Dec. 2023 )
=	(207.103	-	480.351)	/	2468.893
=	-0.11

where

	Operating Assets		(A: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1786.252	-	1579.149
=	207.103

	Operating Liabilities		(A: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	658.035	-	141.674	-	36.01
=	480.351

CARsgen Therapeutics Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(207.103	-	480.351)	/	2263.429
=	-0.12

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1786.252	-	1579.149
=	207.103

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	658.035	-	141.674	-	36.01
=	480.351

CARsgen Therapeutics Holdings Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of CARsgen Therapeutics Holdings's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

CARsgen Therapeutics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARsgen Therapeutics Holdings Ltd (HKSE:02171) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN

Website

https://www.carsgen.com

CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America.

Executives

Bei Jing Shen Nong Tou Zi Guan Li Gu Fen You Xian Gong Si	2102 Investment manager
Candock Holdings Limited	2501 Other
Yi Jie Sheng Wu Ji Shu Kong Gu You Xian Gong Si	2501 Other
Yi De Kong Gu You Xian Gong Si	2501 Other
Quan Zhou Shi Ding Wo Chuang Feng Tou Zi Zhong Xin You Xian He Huo	2501 Other
Yang Xuehong	2501 Other
Wang Huamao	2401 A concert party to an agreement to buy shares
Li Zonghai	2401 A concert party to an agreement to buy shares
Guo Bingsen	2401 A concert party to an agreement to buy shares
Accure Biotech Limited	2501 Other
Cart Biotech Limited	2501 Other
Chen Haiou	2501 Other
Guo Xiaojing	2501 Other
He Xi Holdings Limited	2501 Other
Redelle Holding Limited	2501 Other

CARsgen Therapeutics Holdings Headlines

No Headlines